» Articles » PMID: 25542976

Natural History of β-cell Adaptation and Failure in Type 2 Diabetes

Overview
Journal Mol Aspects Med
Date 2014 Dec 28
PMID 25542976
Citations 112
Authors
Affiliations
Soon will be listed here.
Abstract

Type 2 diabetes mellitus (T2D) is a complex disease characterized by β-cell failure in the setting of insulin resistance. The current evidence suggests that genetic predisposition, and environmental factors can impair the capacity of the β-cells to respond to insulin resistance and ultimately lead to their failure. However, genetic studies have demonstrated that known variants account for less than 10% of the overall estimated T2D risk, suggesting that additional unidentified factors contribute to susceptibility of this disease. In this review, we will discuss the different stages that contribute to the development of β-cell failure in T2D. We divide the natural history of this process in three major stages: susceptibility, β-cell adaptation and β-cell failure, and provide an overview of the molecular mechanisms involved. Further research into mechanisms will reveal key modulators of β-cell failure and thus identify possible novel therapeutic targets and potential interventions to protect against β-cell failure.

Citing Articles

Analysis of the morbidity characteristics and related factors of pulmonary nodules in patients with type 2 diabetes mellitus: a retrospective study.

Yang J, Wang W, Lu Y, Li C, Wei S, Sun W BMC Endocr Disord. 2025; 25(1):26.

PMID: 39885490 PMC: 11780996. DOI: 10.1186/s12902-025-01857-9.


The Promising Potency of Sodium-Glucose Cotransporter 2 Inhibitors in the Prevention of and as Treatment for Cognitive Impairment Among Type 2 Diabetes Patients.

Zhang Y, Liao X, Xu J, Yin J, Li S, Li M Biomedicines. 2025; 12(12.

PMID: 39767690 PMC: 11673520. DOI: 10.3390/biomedicines12122783.


Enhanced dynorphin expression and secretion in pancreatic beta-cells under hyperglycemic conditions.

Movahed M, Louzada R, Blandino-Rosano M Mol Metab. 2024; 92:102088.

PMID: 39736444 PMC: 11846442. DOI: 10.1016/j.molmet.2024.102088.


Endothelial Dysfunction Using Flow-mediated Dilatation Among Individuals with Pre-impaired Glucose Tolerance (Pre-IGT).

Salmon J, Magbuhat A, Guerrero-Sali R, Purino F, Macindo J, Mercado-Asis L J ASEAN Fed Endocr Soc. 2024; 39(2):13-19.

PMID: 39620187 PMC: 11604354. DOI: 10.15605/jafes.039.02.19.


Sweet Spot Regulation of Maternal Metabolic Health and Nutrition on β-Cell Mass in the Offspring.

Chung G, Wong A, Her T, Alejandro E Adv Anat Embryol Cell Biol. 2024; 239:157-197.

PMID: 39283486 DOI: 10.1007/978-3-031-62232-8_7.


References
1.
Petersen L, Storling J, Heding P, Li S, Berezin V, Saldeen J . IL-1beta-induced pro-apoptotic signalling is facilitated by NCAM/FGF receptor signalling and inhibited by the C3d ligand in the INS-1E rat beta cell line. Diabetologia. 2006; 49(8):1864-75. DOI: 10.1007/s00125-006-0296-2. View

2.
Lupi R, Del Guerra S, Mancarella R, Novelli M, Valgimigli L, Pedulli G . Insulin secretion defects of human type 2 diabetic islets are corrected in vitro by a new reactive oxygen species scavenger. Diabetes Metab. 2007; 33(5):340-5. DOI: 10.1016/j.diabet.2007.03.005. View

3.
Masters S, Dunne A, Subramanian S, Hull R, Tannahill G, Sharp F . Activation of the NLRP3 inflammasome by islet amyloid polypeptide provides a mechanism for enhanced IL-1β in type 2 diabetes. Nat Immunol. 2010; 11(10):897-904. PMC: 3103663. DOI: 10.1038/ni.1935. View

4.
Bonner-Weir S, Deery D, Leahy J, Weir G . Compensatory growth of pancreatic beta-cells in adult rats after short-term glucose infusion. Diabetes. 1989; 38(1):49-53. DOI: 10.2337/diab.38.1.49. View

5.
Back S, Kaufman R . Endoplasmic reticulum stress and type 2 diabetes. Annu Rev Biochem. 2012; 81:767-93. PMC: 3684428. DOI: 10.1146/annurev-biochem-072909-095555. View